When one unnecessary procedure leads to many…
What happens when one low-value test leads to a "cascade" of expensive and harmful procedures? More
The monopolization of health care goes beyond hospitals
We know that consolidation among hospitals and insurance companies leads to higher prices. But what about consolidation in other areas of health care? More
Deprescribing Champions: Maisha Draves
Why measuring the outcomes of deprescribing is key for culture change, from family physician Maisha Draves at Kaiser Permanente. More
Accelerated drug approval has not come with accelerated evidence
Is the FDA's accelerated approval program resulting in better cancer drugs? Two new studies provide insight... More
Is this $2 million gene therapy drug priced “fairly”?
The approval of a new gene therapy to treat spinal muscular atrophy has created a hot debate in the health policy world about whether or not the drug's $2.1 million price tag is too expensive or a fair price. More
The public health epidemic no one is talking about…
While we rush to fix the opioid crisis, are we ignoring another widespread drug problem? More
How pharmacists can be “deprescribing champions”
A group of pharmacists from Lifespan/Rhode Island Hospital answer our questions about how pharmacists can promote deprescribing. More
Is our health care system prepared for a pediatric mental health crisis?
Is our health care system prepared to treat more behavioral health problems in younger people? So far, the answer is no. More
Why AI? Questioning the role of artificial intelligence in health care
Health care experts explain the potential downsides to the artificial intelligence "revolution." More
Prescribing and the 4Ms: How to prevent harm to older Americans
In Health Affairs Grantwatch blog, Shannon Brownlee and Terry Fulmer describe how the Lown Institute and John A. Hartford Foundation are working together to reduce medication overload. More
Can health journalism be saved?
Popular health news often fails to reflect the incrementalism and nuance of medical discoveries, instead hyping unproven treatments. Can we save health journalism? More
How much does health care affect longevity?
Much of the political discourse around health focuses on expanding access to health insurance. But how much does health care really matter for health? More
Timing: The third element of value-based care
When we think of initiatives to improve health care value, we generally think of policies to reduce volume or price. But what if there was another way to improve the bang for each health care buck? More
Private equity investments in physician practices and overuse
Physician practices are increasingly being bought up by private equity firms. What does this mean for quality of care and overuse? More
The missed opportunities of palliative care
Why is palliative care still underutilized, despite the improvements in quality of life it offers patients with serious illness? More
Top “fixes” for health equity and diversity
Solutions for increasing racial and gender equity in health care, from the Atlantic Pulse conference. More
Investigating the “spin cycle” in cardiovascular research
A new study in JAMA shows how often cardiovascular trials contain misleading information... More
Social isolation: Another growing public health problem for older Americans
Clinicians and public health experts are calling attention to the health risks and financial implications of widespread loneliness. More
How do we “fix” medical training? Here are some ideas
At the Atlantic Pulse conference, health care experts proposed several "fixes" for the medical education system. More
The culture that drives medication overload
Why is the culture the drives overprescribing so tough to change? Read the new op-ed from Theresa Brown, RN, to find out more! More